Let’s take a look at top 10 health technology innovation ready to take over 2019.
2018 has been the year for a significant number of vertical integrations, for instance, CVS Health’s $68mn takeover of health insurer Aetna. It will gain significant negotiating power to reduce costs for payers and patients, develop personalised solutions and improve overall outcomes by influencing more of the supply chain. It will also promote the eradication of delays in process by removing any third parties within traditional business models. Optum’s acquisition of the DaVita Medical Group, Humana and Kindred Healthcare and Cigna and Express Scripts are other notable integrations.
As per reports, not only has the number of healthcare deals more than doubled in the last five years, the size of deals has also grown as a result of repeat investor interest. This highlights the fact that this trend is here to stay.
Consumer genetics and research companies have grown in popularity and scale as consumers get more involved in the management of their health. The want of people to further understand their genetic makeup has lead personal genomics and biotech company 23andMe to become one of the largest consumer-based organisations worldwide. The company has entered a four-year collaboration with GSK to develop new treatments this year, but using human genetics as the basis for discovery.
Pharmaceutical companies are looking to even remove hereditary genes which pass diseases down generations, not only looking to develop treatments by analysing human genetics. Human embryos were successfully ‘edited’ through gene editing tool CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeats) in 2017, eradicating hypertrophic cardiomyopathy within 42 embryos.